氧化应激
化学
药理学
固体脂质纳米粒
白杨素
抗氧化剂
海马结构
淀粉样β
生物化学
生物物理学
纳米颗粒
疾病
神经科学
医学
生物
病理
纳米技术
材料科学
类黄酮
作者
Aishwarya Vedagiri,Thangarajan Sumathi
出处
期刊:Neuropeptides
[Elsevier BV]
日期:2016-03-21
卷期号:58: 111-125
被引量:130
标识
DOI:10.1016/j.npep.2016.03.002
摘要
Alzheimer's disease (AD) is the most prevalent form of dementia. Amyloid-β25–35 (Aβ25–35), a well-established neurotoxicant, is reported to be involved in the etiology of AD. Chrysin (CN) with its wide range of biological activities in terms of reversing the neuronal damage once induced is limited due to its compromised bioavailability. Solid lipid nanoparticles (SLNs) on the other hand due to its improved protein stability, avoids proteolytic degradation, as well as sustained release of the incorporated molecules could be widely applied as a drug delivery vehicle. Hence, in the present investigation, we prepared CN loaded SLNs (CN-SLNs) and investigated its therapeutic role in alleviating Aβ25–35 administered neuronal damage. All the antioxidant enzymes and non-antioxidant enzyme in hippocampus were reduced significantly (P < 0.01) in the Aβ25–35 injected group, whereas lipid peroxidation and acetylcholine esterase were increased significantly (P < 0.01). These changes were restored significantly (P < 0.01) by CN-SLNs (5 mg/kg and 10 mg/kg) and (P < 0.05) by free CN (50 mg/kg and 100 mg/kg). Aβ25–35 also resulted in poor memory retention in behavioral tasks and histopathological sections of the hippocampal region showed the extent of neuronal loss which was thereby restored back on treatment with CN-SLNs and free CN. Our findings demonstrate that the therapeutic efficacy of CN could be attained at lower dose and also its oral bioavailability could be increased by encapsulating CN in SLNs. Thus the results suggest that CN-SLNs could be used as a potential therapeutic and a brain targeting strategy to combat the global burden of Alzheimer's disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI